Imunon Inc (NASDAQ: IMNN)’s stock price has soared by 4.39 in relation to previous closing price of 1.14. Nevertheless, the company has seen a gain of 7.69% in its stock price over the last five trading days. globenewswire.com reported 2024-09-09 that September 18 th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Treat Advanced Ovarian Cancer and Clinical Development Timeline
Is It Worth Investing in Imunon Inc (NASDAQ: IMNN) Right Now?
The 36-month beta value for IMNN is at 2.13. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for IMNN is 13.69M, and currently, shorts hold a 2.80% of that float. The average trading volume for IMNN on September 18, 2024 was 3.02M shares.
IMNN’s Market Performance
The stock of Imunon Inc (IMNN) has seen a 7.69% increase in the past week, with a -1.65% drop in the past month, and a 11.21% gain in the past quarter. The volatility ratio for the week is 5.61%, and the volatility levels for the past 30 days are at 8.06% for IMNN. The simple moving average for the past 20 days is 4.85% for IMNN’s stock, with a 10.54% simple moving average for the past 200 days.
IMNN Trading at -3.79% from the 50-Day Moving Average
After a stumble in the market that brought IMNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.40% of loss for the given period.
Volatility was left at 8.06%, however, over the last 30 days, the volatility rate increased by 5.61%, as shares sank -5.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.69% lower at present.
During the last 5 trading sessions, IMNN rose by +5.88%, which changed the moving average for the period of 200-days by +30.00% in comparison to the 20-day moving average, which settled at $1.1315. In addition, Imunon Inc saw 75.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IMNN starting from Lindborg Stacy, who purchase 25,000 shares at the price of $0.98 back on Aug 15 ’24. After this action, Lindborg Stacy now owns 264,166 shares of Imunon Inc, valued at $24,500 using the latest closing price.
Tardugno Michael H, the Executive Chairman of Board of Imunon Inc, purchase 25,000 shares at $1.03 during a trade that took place back on Aug 15 ’24, which means that Tardugno Michael H is holding 353,346 shares at $25,750 based on the most recent closing price.
Stock Fundamentals for IMNN
Current profitability levels for the company are sitting at:
- -2.82 for the present operating margin
- 0.9 for the gross margin
The net margin for Imunon Inc stands at -2.56. The total capital return value is set at -4.31. Equity return is now at value -143.19, with -94.15 for asset returns.
Based on Imunon Inc (IMNN), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -13.41. The debt to equity ratio resting at 0.37. The interest coverage ratio of the stock is 0.1.
Currently, EBITDA for the company is -20.31 million with net debt to EBITDA at 0.21. When we switch over and look at the enterprise to sales, we see a ratio of 1.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.
Conclusion
In conclusion, Imunon Inc (IMNN) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
